Understanding Dose Equivalents and Treatment Pathways
Mounjaro vs Wegovy Dose Equivalent: Mechanism Differences
The mounjaro vs wegovy dose equivalent comparison begins with understanding their distinct mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones to reduce appetite and promote satiety after smaller meals. Mounjaro utilises tirzepatide, a dual-action treatment targeting both GIP and GLP-1 receptors simultaneously. This fundamental difference means direct dose equivalents cannot be calculated using simple numerical comparisons. The medications work through different pathways, requiring individual clinical assessment to determine appropriate starting doses.
When evaluating mounjaro vs wegovy dose equivalent options, prescribers consider your medical history, current BMI, and treatment goals. Wegovy follows a structured five-step escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks. Mounjaro progresses through six dose levels from 2.5mg to 15mg, typically escalating every four weeks based on individual response and tolerability. Both prescription-only medicines require careful monitoring during dose transitions. Your EverydayMeds prescriber will create a personalised escalation schedule based on clinical indicators rather than attempting mathematical dose conversions.
Pricing Comparison: Wegovy vs Mounjaro Dose Equivalent Costs
Understanding the mounjaro vs wegovy dose equivalent financial commitment helps inform treatment decisions. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99 (weeks 1-4), progressing to 0.5mg at £94.99 (weeks 5-8), then 1mg at £99.99 (weeks 9-12). The 1.7mg dose costs £139.99 (weeks 13-16), with maintenance 2.4mg at £209.99 from week 17 onwards. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our bundle options provide convenient supply management, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first 12 weeks of treatment.
When comparing mounjaro vs wegovy dose equivalent value, consider storage advantages and treatment duration. Wegovy offers superior travel convenience with 6 weeks room temperature storage once removed from the fridge, compared to Mounjaro's 21-day limitation. This extended stability reduces waste and provides flexibility for busy lifestyles. Both treatments are available through EverydayMeds' streamlined ordering process, ensuring consistent supply without interruption. Our bundles like the Progress Duo (0.5mg & 1mg) at £189.99 provide seamless dose progression, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99.
Clinical Evidence: Wegovy vs Mounjaro Dose Equivalent Outcomes
The STEP clinical trial programme demonstrates Wegovy's efficacy across its dose equivalent range. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 showed enhanced results of approximately clinically studied weight loss when combined with intensive behavioural therapy, whilst STEP 5 demonstrated sustained clinically studied weight loss at two years.
When evaluating mounjaro vs wegovy dose equivalent clinical outcomes, it's important to note that direct head-to-head trials have not been conducted using identical study populations and endpoints. Both treatments have demonstrated significant efficacy in their respective clinical programmes, but comparison of percentage weight loss figures would not provide accurate guidance for individual patients. Your prescriber will consider your medical profile against both treatment options' clinical evidence to determine the most appropriate choice.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy's mechanism centres on GLP-1 receptor activation in key areas of the brain that control appetite and food intake. Once injected subcutaneously, semaglutide binds to GLP-1 receptors in the hypothalamus, reducing hunger signals and promoting feelings of fullness. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. This dual action on both central appetite control and peripheral digestive processes creates a comprehensive approach to weight management. Unlike stimulant-based appetite suppressants, Wegovy works through natural hormone pathways, supporting gradual, sustainable weight loss when combined with lifestyle modifications. The once-weekly injection schedule maintains consistent therapeutic levels throughout the treatment period.
Ordering Process: From Assessment to Delivery
Accessing mounjaro vs wegovy dose equivalent treatments through EverydayMeds begins with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your submission within standard 3 working days (or 24 hours with express service), ensuring safe, appropriate treatment selection based on MHRA licensing criteria. Upon approval, your Wegovy is dispatched via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C storage temperature during transit. Each delivery includes comprehensive patient information leaflets, injection technique guidance, and direct contact details for ongoing clinical support. Our GPhC-registered pharmacy team (GPhC #9012878) maintains full medication records and provides dose escalation reminders throughout your treatment journey.
Storage and Practical Considerations
The mounjaro vs wegovy dose equivalent comparison includes important practical differences in medication handling and storage requirements. Wegovy must be stored in the refrigerator at 2-8°C before first use, but offers exceptional flexibility once removed, maintaining potency for up to 6 weeks at room temperature below 30°C. This storage advantage significantly exceeds Mounjaro's 21-day room temperature limitation, providing greater convenience for travel, work schedules, or unexpected disruptions. Each Wegovy pen uses Novo Nordisk's FlexTouch technology, featuring a simple dial-and-inject mechanism with dose confirmation window. The pen contains four doses of your prescribed strength, lasting exactly four weeks with once-weekly injections. Always check the solution appears clear and colourless before injection, discarding any pen showing particles, cloudiness, or discolouration.
Dose Escalation Strategies: Personalised Treatment Pathways
Understanding mounjaro vs wegovy dose equivalent escalation protocols helps set realistic treatment expectations and timeline planning. Wegovy follows a medically established progression designed to minimise gastrointestinal side effects whilst optimising therapeutic benefits. The mandatory four-week intervals at each dose level allow your body to adjust gradually to increasing semaglutide concentrations. Skipping doses or accelerating escalation is not recommended and may increase the risk of nausea, vomiting, or other adverse effects.
When comparing mounjaro vs wegovy dose equivalent escalation approaches, both treatments prioritise patient tolerability over rapid dose advancement. Your EverydayMeds prescriber may recommend extending time at lower doses if you experience side effects, or maintaining sub-maximal doses if achieving satisfactory weight management outcomes. Regular check-ins during dose transitions ensure optimal balance between efficacy and tolerability. Some patients achieve their weight management goals before reaching maximum maintenance doses, demonstrating the importance of individualised treatment approaches rather than standardised dose equivalent calculations.
Making Your Treatment Decision: Expert Clinical Guidance
The final mounjaro vs wegovy dose equivalent decision requires comprehensive evaluation of your medical profile, lifestyle factors, and treatment preferences. Both treatments are available from EverydayMeds, providing you with flexibility to switch between options under clinical supervision if initial treatment response is suboptimal. Your prescriber will consider factors including previous weight management attempts, concurrent medications, travel requirements, and injection preferences when recommending treatment pathways. Regular monitoring appointments allow treatment optimisation based on your individual response patterns rather than predetermined dose equivalent assumptions.
EverydayMeds' clinical team provides ongoing support throughout your weight management journey, offering expert guidance on dose timing, injection technique, and lifestyle integration strategies. Our comprehensive approach ensures you receive personalised care that extends beyond simple medication supply. Whether you begin with Wegovy or Mounjaro, our prescribers remain available for treatment adjustments, side effect management, and long-term maintenance planning. Contact our clinical team to discuss your mounjaro vs wegovy dose equivalent questions and begin your assessment today.
Ready to start your weight management journey? Visit our weight loss collection to begin your clinical assessment. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 for optimal value. Our expert prescribers are standing by to guide your treatment selection and ensure safe, effective outcomes. Both Wegovy and Mounjaro are available from EverydayMeds, giving you access to comprehensive weight management solutions backed by clinical excellence and pharmaceutical expertise. Take the first step towards sustainable weight management with the UK's trusted prescription weight loss specialists.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
